Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Human Microbiome

University of Calgary

$93,999.00

Characterizing the fecal microbiome and bacteria-derived volatile organic compounds in patients with nonalcoholic fatty liver disease (NAFLD)

EF 2008-09

Résumé
Background: The prevalence of obesity in Canadian adults and children has dramatically increased. Many experts cite obesity as a significant public health hazard. The vast communities of bacteria (microbiota) that live in the human intestine play a key role in human health; there is also evidence that implicates the gut microbiota in a variety of diseases, including obesity. For example, gut bacteria in obese patients enable them to harvest greater energy from their diet. Nonalcoholic fatty liver disease (NAFLD) is commonly associated with obesity and may progress to cirrhosis of the liver, hepatocellular cancer, or liver failure. The pathological features of NAFLD are very similar to liver injury induced by chronic ingestion of ethanol. A link between obesity, NAFLD and the intestinal microbiota may lie in the multitude of metabolites such as volatile organic compounds (VOCs) that are produced by bacteria in the gut. Hypothesis: Patients with NAFLD have alterations in their gut bacteria and/or associated VOCs that are relevant to the development of this disease. Methods: This study will involve subjects with biopsy proven NAFLD and healthy controls. Molecular methods will be used to describe and quantify the fecal microbiota. Volatile organic compounds will be measured in fecal samples using mass spectrometry. Hydrogen breath testing will assess small bowel bacterial overgrowth. Computer analysis will discern whether there are significant differences between the composition or metabolic activities of fecal bacteria in NAFLD patients and healthy subjects. Relevance: With the obesity epidemic in Canada, the burden of NAFLD will continue to rise. The major concern in patients with NAFLD is the risk of developing advanced scarring of the liver leading to significant complications. This study will examine previously unexplored links between gut bacteria and the development of NAFLD, and may identify new ways to prevent or treat this common disease.
Programme
Catalyst Grant: Human Microbiome
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
172964
Name
Rioux Kevin P
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
Characterizing the fecal microbiome and bacteria-derived volatile organic compounds in patients with nonalcoholic fatty liver disease (NAFLD)
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$93,999
Cihrequipment2
$2,000
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
Bacterial Metabolism; Intestinal Microbiome; Nonalcoholic Fatty Liver Disease; Obesity; Quantitative Real Time Pcr; Terminal Restriction Fragment Length Polymorphism
Abstract
Background: The prevalence of obesity in Canadian adults and children has dramatically increased. Many experts cite obesity as a significant public health hazard. The vast communities of bacteria (microbiota) that live in the human intestine play a key role in human health; there is also evidence that implicates the gut microbiota in a variety of diseases, including obesity. For example, gut bacteria in obese patients enable them to harvest greater energy from their diet. Nonalcoholic fatty liver disease (NAFLD) is commonly associated with obesity and may progress to cirrhosis of the liver, hepatocellular cancer, or liver failure. The pathological features of NAFLD are very similar to liver injury induced by chronic ingestion of ethanol. A link between obesity, NAFLD and the intestinal microbiota may lie in the multitude of metabolites such as volatile organic compounds (VOCs) that are produced by bacteria in the gut. Hypothesis: Patients with NAFLD have alterations in their gut bacteria and/or associated VOCs that are relevant to the development of this disease. Methods: This study will involve subjects with biopsy proven NAFLD and healthy controls. Molecular methods will be used to describe and quantify the fecal microbiota. Volatile organic compounds will be measured in fecal samples using mass spectrometry. Hydrogen breath testing will assess small bowel bacterial overgrowth. Computer analysis will discern whether there are significant differences between the composition or metabolic activities of fecal bacteria in NAFLD patients and healthy subjects. Relevance: With the obesity epidemic in Canada, the burden of NAFLD will continue to rise. The major concern in patients with NAFLD is the risk of developing advanced scarring of the liver leading to significant complications. This study will examine previously unexplored links between gut bacteria and the development of NAFLD, and may identify new ways to prevent or treat this common disease.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rioux, Kevin P; Kothandaraman, Maitreyi
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $27,999~ $2,000~Inst of Nutr Metabolism &Diab~ $66,000~ $0~